CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Scientific Officer sold 666 shares at an average $153.21 ($102,039)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $153.84 ($153,839)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $155.50 ($155,502)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $155.64 ($155,636)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $155.78 ($155,778)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $156.97 ($156,973)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $155.82 ($155,817)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $159.16 ($159,162)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $162.64 ($162,641)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $159.56 ($159,556)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $166.28 ($166,284)
- 4 Other acquisition Chief Executive Officer acquired 10,000 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $170.38 ($170,384)
- 4 Other acquisition Chief Financial Officer acquired 10,000 shares (other)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $166.00 ($166,000)
- 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $163.59 ($163,595)
Page 2 of 11 · 215 filings